BlueWind Medical today announced two-year results from a study of its Revi implantable tibial neuromodulation (iTNM) system.

The FDA labeled a recall of integrated arterial catheters made by Medline Class I, the most serious kind of recall.

Neuronetics (Nasdaq:STIM) announced today that it priced an underwritten public offering of common stock at approximately $18 ...

Globus Medical (NYSE:GMED) announced today that it agreed to acquire chronic pain treatment developer Nevro (NYSE:NVRO).

MicroTransponder recently announced positive real-world outcomes for its Vivistim vagus nerve stimulation (VNS) system.

BD (NYSE: BDX) announced that its board unanimously authorized management to pursue the separation of its Life Sciences ...

Zimmer Biomet (NYSE: ZBH) shares dipped slightly today on fourth-quarter results that came in just ahead of the consensus ...

RenovoRx (Nasdaq:RNXT) announced that it priced an underwritten public offering of common stock worth proceeds of $12.1 ...

In January 2023, Baxter announced plans to spin its renal care and acute therapies units into an independent, publicly traded ...

GE HealthCare announced a $138 million investment to expand its contrast media fill/finish manufacturing site in Cork, ...

The Financial Times reports today that an activist investor wants BD (NYSE:BDX) to sell off its Life Sciences business unit.

Wandercraft already offers the FDA-cleared Atalante X exoskeleton for individuals with spinal cord injuries (SCIs). Atalante ...